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Background: Chlorine bleach, or hypochlorous acid, is themost reactive two-electron oxidant produced in appre-
ciable amounts in our bodies. Neutrophils are the main source of hypochlorous acid. These champions of the in-
nate immune system use it to fight infection but also direct it against host tissue in inflammatory diseases.
Neutrophils contain a rich supply of the enzymemyeloperoxidase. It uses hydrogen peroxide to convert chloride
to hypochlorous acid.
Scope of review:We give a critical appraisal of the best methods to measure production of hypochlorous acid by
purified peroxidases and isolated neutrophils. Robust ways of detecting it inside neutrophil phagosomes where
bacteria are killed are also discussed. Special attention is focused on reaction-based fluorescent probes but their
visual charm is tempered by stressing their current limitations. Finally, the strengths and weaknesses of bio-
marker assays that capture the footprints of chlorine in various pathologies are evaluated.
Major conclusions: Detection of hypochlorous acid by purified peroxidases and isolated neutrophils is best
achieved by measuring accumulation of taurine chloramine. Formation of hypochlorous acid inside neutrophil
phagosomes can be tracked using mass spectrometric analysis of 3-chlorotyrosine and methionine sulfoxide in
bacterial proteins, or detection of chlorinatedfluorescein on ingestible particles. Reaction-basedfluorescent probes
can also be used tomonitor hypochlorous acid during phagocytosis. Specific biomarkers of its formation during in-
flammation include 3-chlorotyrosine, chlorinated products of plasmalogens, and glutathione sulfonamide.
General significance: These methods should bring new insights into how chlorine bleach is produced by peroxi-
dases, reacts within phagosomes to kill bacteria, and contributes to inflammation. This article is part of a Special
Issue entitled Currentmethods to study reactive oxygen species - pros and cons and biophysics of membrane pro-
teins. Guest Editor: Christine Winterbourn.© 2013 Elsevier B.V. All rights reserved.1. Introduction
Chlorine bleach or hypochlorous acid is exceptionally toxic. It is pro-
duced by white blood cells and kills all types of bacteria. At the right
dose, it is also lethal to our own cells. Hypochlorous acid is toxic because
it oxidizes many biological molecules. Its tendency to bleach chemicals
was first noticed by the great Swedish chemist Carl Wilhelm Scheele
who discovered chlorine in 1774. He was also aware of its toxicity but
failed to appreciate the dangers of chlorine gas, dying young after
succumbing to its vapours [1]. Even though the antiseptic properties
of chlorinewere realised early, Semmelweis had to pleadwith surgeons
to sanitize their operating theatres with bleach [2]. No one needed to be
convinced of its toxicity during World War 1. Ironically, while infected
wounds were cleansed with Dakin's dilute solution of hypochlorite,
the toxic fumes of chlorine gas were blown across the battlefields ofethods to study reactive oxygen
roteins. Guest Editor: Christine
4 3 3641083.
ights reserved.Europe to asphyxiate soldiers [3,4]. At this time, chlorinewas beginning
to beused inmunicipalwater supplies to eradicatewater borne diseases
from urban populations. In 1967 Klebanoff discovered that the enzyme
myeloperoxidase uses hydrogen peroxide to oxidize chloride to a po-
tent bactericidal agent [5]. It was then obvious that chlorine bleach
must be a leading participant in our battle against infections and the se-
quelae of inflammation. From that time, methods with ever increasing
sophistication have been developed to explore the biology and patholo-
gy of chlorine bleach. In this review we will outline the basic chemistry
and biochemistry of hypochlorous acid, and describe the most robust
methods for measuring its production by peroxidases in vitro, within
cells of the innate immune system, and at sites of inflammation.
Neutrophils, the most abundant white blood cells in the circulation
of humans, are the major source of hypochlorous acid in our bodies
[6,7].When stimulated, they undergo a burst of respiration inwhich ox-
ygen is reduced to superoxide by the NADPH oxidase that is assembled
on their plasmamembrane. Neutrophils contain rich stores of the haem
enzymemyeloperoxidase. It uses superoxide and hydrogen peroxide to
convert chloride to hypochlorous acid [8]. When a neutrophil ingests
and kills a bacterium, hypochlorous acid is produced within the phago-




Fig. 1. Activation of neutrophils. (A) Neutrophils phagocytosing bacteria as indicated by
arrows. “This research was originally published in Blood. Hampton MB, Kettle AJ and
Winterbourn CC, Inside the neutrophil phagosome. Blood. 1998;92:3007–3017. © the
American Society of Hematology.” [173] (B) Neutrophils (N) producing hydrogen perox-
ide when adherent to basement membrane (GBM) and when (C) stimulated by phorbol
myristate acetate. Hydrogen peroxide was visualized by the electron-dense deposits of
cerium (see arrows) [10].
Fig. 2.The pHprofile for reactive chlorine species. The relative concentrations ofmolecular
chlorine (Cl2; green), hypochlorous acid (HOCl; red) and hypochorite (−OCl; blue) were
calculated at 140 mM chloride using K = 1.3 × 10−3 M2 for reaction 1 and a pKa of 7.44
for reaction 2.
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plexes on host tissue where they undergo frustrated phagocytosis and
direct hypochlorous acid against the tissue [10] (Fig. 1B). Soluble stimuli
cause the release of myeloperoxidase and hydrogen peroxide to the
extracellular environment where hypochlorous acid will react with a
variety of biological nucleophiles (Fig. 1C) [11]. Monocytes and macro-
phages also contain myeloperoxidase but in much lower amounts than
neutrophils.Hypochlorous acid should be viewed as a doubled-edged sword in
biology. Its extreme toxicity toward virtually all bacteria is a boon for
host defence but its facile reactivity with myriad biological molecules
makes it a dangerous oxidant during inflammation.We are also learning
that hypochlorous acid may play another vital role in biology by tying
strands of collagen IV together in an indispensable structural cross-
linking reaction [12]. This reaction is catalysed by peroxidasin 1, also
known as vascular peroxidase 1 [13]. The methods outlined in this
chapter will be valuable in elucidating this newly discovered use of
hypochlorous acid and how peroxidasin 1 contributes to normal physi-
ology and exacerbates inflammation [14,15].
2. The chemistry of chlorine bleach
Chlorine bleach is an ephemeral species that often leads to a non-
specific footprint when it reacts with biomolecules. Consequently,
detecting this fleeting oxidant in biological systems requires an appreci-
ation of its potential chemistry. When the native or ferric form of
myeloperoxidase reacts with hydrogen peroxide it forms the redox
intermediate Compound I [16], which has a two electron reduction
potential of 1.16 V [17]. Thus, Compound I ismore likely to oxidize chlo-
ride to hypochlorous acid (E0′HOCl/Cl− 1.28 V) thanmolecular chlorine
(Cl2/Cl− 1.39 V) [18]. However, the odour of chlorine gas wafting from
solutions ofmyeloperoxidase, chloride andhydrogenperoxide [19], and
its identification by mass spectrometry [20], demonstrates that under
physiological conditions hypochlorous acid is in equilibrium with mo-
lecular chlorine. Dichlorine monoxide (Cl2O) is another species of chlo-
rine that is relevant to the understanding of the biological chemistry of
hypochlorous acid. These reactive chlorine species form an overall equi-
libriumwith hypochlorite (−OCl), which is balanced by pH and the con-
centration of chloride (reactions 1, 2 & 3).
Cl2 þ H2O b  N HOCl þ Cl− þ Hþ ð1Þ
HOCl b  N −OCl þ Hþ ð2Þ
2HOCl b  N Cl2O þ H2O ð3Þ
The equilibrium constant for reaction 1 (1.3 × 10−3 M2) [21] and
the pKa of reaction 2 (7.44 at 37 °C) [22] determine that hypochlorous
acid and hypochlorite are themajor species present under physiological
conditions (Fig. 2). At pH 7.4 the concentrations of hypochlorous acid
and hypochlorite are approximately equal while molecular chlorine
Fig. 3. The reactions of myeloperoxidase. Ferric MPO reacts with hydrogen peroxide to
form Compound I. Compound I then oxidizes chloride, bromide, iodide or thiocyanate to
their respective hypohalous acids in a two-electron reaction. Compound I is also reduced
by one-electron donors, including hydrogen peroxide and organic substrate (RH) such as
tyrosine, tryptophan, ascorbate, or serotonin to produce Compound II and a radical product.
The classical peroxidation cycle is completed when substrates such as tyrosine, ascorbate
andurate reduce Compound II back to the ferric enzyme. Superoxide reacts readilywith fer-
ric MPO, Compound I and Compound II.
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pH 6.5, which occurs during inflammation in the airways [23], molecular
chlorine makes up only about 0.003% of reactive chlorine. It accounts for
100 fold less at pH 7.8which exists in neutrophil phagosomeswhen bac-
teria are being ingested and killed [24].
Hypochlorous acid is kinetically the most reactive two-electron oxi-
dant produced in appreciable amounts in our bodies. Its reactivity with
most substrates exceeds that of hydrogen peroxide, hydroperoxides,
and peroxynitrite by several orders of magnitude [25]. The rates con-
stants for the reactions of hypochlorous acid, however, vary over
many orders of magnitude [26–28]. Thus, hypochlorous acid should be
considered as a highly reactive but selective oxidant. It reacts over-
whelmingly with cysteine and methionine residues (k ~ 108 M−1 s−1)
and to a much lesser extent with lysine, tryptophan, terminal amines,
and histidine (k ~ 104–105 M−1 s−1) [28,29]. Reaction with amine
groups produces chloramines. These are weaker but more selective oxi-
dants than hypochlorous acid [30,31]. When formed on protein residues
they breakdown to form carbonyls as well as ammonia chloramines
(NH2Cl and NHCl2) [32]. Amino acid chloramines have minimal antimi-
crobial activitywhereasNH2Cl andNHCl2 have similar bactericidal poten-
cy to hypochlorous acid [32]. Alternative products of myeloperoxidase
include hypobromous acid and hypothiocyanite, which are formed
from the oxidation of bromide and thiocyanate, respectively [6,7]. For
most amino acid residues hypochlorous acid reacts 30–100 fold slower
than does hypobromous acid [33]. The exceptions are methionine and
cysteine residues which react 10-fold faster with hypochlorous acid.
Hypothiocyanite reacts rapidly with cysteine residues only [34].
The absolute rate constant for reaction of hypochlorous acidwith ty-
rosine residues at pH 7.4 is only 40 M−1 s−1, which indicates that di-
rect chlorination under physiological conditions is unfavourable [28]
(see Section 7). Althoughmolecular chlorine is a minor form of reactive
chlorine, it is a considerably stronger electrophile than hypochlorous
acid [35,36]. Molecular chlorine should react at diffusion controlled
rates withmost biological nucleophiles. Hypochlorite is much less reac-
tive than hypochlorous acid so that its reactions in biological systems
can essentially be ignored [26].
For a particular reaction of chlorine bleach, the chlorine species that
dominates depends on their relative rate constants and respective con-
centrations. For example, chlorination of tyrosine involves reaction with
the phenolate formof this amino acid. The rate constant for hypochlorous
acid with a phenolate is 2 × 104 M−1 s−1 whereas that for molecular
chlorine will be at least 109 M−1 s−1 [26]. Thus at pH 7.4, where the
concentration of hypochlorous acid is 2.5 × 105 times that of molecular
chlorine, both species would be expected to contribute to chlorination.
However, with the sulfur containing amino acids the rate constants
for both chlorine species approach the diffusion limit [26]. Hence,
hypochlorous acid will be the major oxidant of these amino acids. In
the biological milieu the reactions of hypochlorous acid with thiols
and thioethers should predominate, so hypochlorous acid will govern
the chemistry of reactive chlorine species. Only after methionine and
cysteine residues have been oxidized, might the reactions of molecular
chlorine become relevant. This could apply in the confined space of a
phagosome where the most susceptible amino acids would be rapidly
consumed due to the enormous flux of hypochlorous acid. Thus, reac-
tions of molecular chlorine could explain why tyrosine trapped within
red blood cell ghosts was chlorinated during phagocytosis [20].
The rate of reaction 3 is so slow (k = 0.12 M−1 s−) that dichlorine
monoxide will not influence the reactions of hypochlorous acid in vivo
[37]. However, this may not be so when reactions of hypochlorous acid
are studied in vitro, especially at high concentrations of hypochlorous
acid or when reaction 3 is catalysed by acids [38]. This is because
dichlorine monoxide is a powerful electrophile and its rates of reaction
can exceed those of hypochlorous acid by seven orders of magnitude
[35,39]. Consequently, even though its concentration will be miniscule
in solutions of hypochlorous acid (K3 = 1.5 × 10−2 M−1 at 37 °C
[38]), it could be the major reactive species when the target moleculeis a weak nucleophile. For example, the rate constants for reaction
of hypochlorous acid with backbone amides, arginine, tyrosine,
phosphoryl-serine, aliphatic double bonds, and DNA are so low that
dichlorine monoxide could contribute to their oxidation [40,41].
3. The enzymology of myeloperoxidase
Before attempting to measure hypochlorous acid production by
myeloperoxidase, it is necessary to appreciate the complexity of the
enzyme's reaction mechanisms. This awareness will help in optimizing
enzyme activity by avoiding inactivation, and in understanding how
inhibitors block production of hypochlorous acid. Initially hydrogen
peroxide reacts with the native or ferric myeloperoxidase to form com-
pound I (Fig. 3) [6,7,11,42]. This redox intermediate then oxidizes chlo-
ride to hypochlorous acid. Compound I is capable of oxidizing myriad
other substrates because of its high reduction potential and the relative-
ly large entrance to its active site. Bromide and thiocyanate are rapidly
oxidized to their hypohalous acids via the same pathway as chloride
[43,44]. Compound I also oxidizes many organic substrates to free radi-
cal intermediates. In the process, myeloperoxidase is converted to Com-
pound II [45]. This latter reaction has amajor influence on production of
hypochlorous acid because compound II does not oxidize chloride and
its reduction back to the ferric enzyme is oftenmuch slower than its for-
mation. For example, hydrogen peroxide can reduce Compound I to
Compound II but reacts with Compound II slowly [46]. Hence at high
concentrations of hydrogen peroxide, hypochlorous acid production
slows over time as Compound II accumulates [47]. Therefore, it is best
to avoid using concentrations of hydrogen peroxide in excess of about
50 μM. If higher amounts of hydrogen peroxide are required, then it is
preferable to use multiple additions of a low concentration or use glu-
cose oxidase to generate a flux of hydrogen peroxide. In kinetic experi-
ments, concentrations of hydrogen peroxide lower than 50 μM should
not be used because its reaction with the enzyme may become rate
limiting.
Accumulation of Compound II is strongly influenced by pH and the
concentration of chloride [47,48]. At a high pH of 7.8 and low concentra-
tions of chloride, Compound I is readily reduced to Compound II. How-
ever, at more acidic pH and high concentrations of chloride Compound
II does not accumulate because its turnover is enhanced. In vivo,
myeloperoxidase is likely to operate betweenpH 6.5 at sites of inflamma-
tion and pH 7.8 inside neutrophil phagosomes [24]. The concentration of
chloride is likely to be about 100–140 mM. Hence, in assays designed to
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initial choice of conditions is pH 7.4 and 140 mM sodium chloride.
Several other substrates promote accumulation of Compound II be-
cause they are good substrates for compound I but poor substrates for
Compound II. These include tryptophan [49], melatonin [50], many
non-steroidal anti-inflammatory drugs [51], and halogenated indoles
[52]. Their presence in assays for hypochlorous acid production should
be avoided or at least understood. Their effects can be attenuated by in-
cluding a good substrate for Compound II in the reaction mixture at a
concentration that minimizes its reaction with Compound I but allows
it to readily reduce Compound II back to the active enzyme. Such sub-
strates include tyrosine (20 μM) [51] and serotonin (5 μM) [50,53].
Any inhibitors of hypochlorous acid production that are less effective
in the presence of tyrosine or serotonin are likely to act by promoting
the accumulation of Compound II. This is by far the most common
mechanism of inhibition of the enzyme.
Often myeloperoxidase is used in combination with xanthine oxi-
dase. Xanthine oxidase with distilled acetaldehyde is employed as a
source of hydrogen peroxide but it also generates superoxide [54]. Su-
peroxide reacts with all the redox intermediates of myeloperoxidase
[8] and in the presence of chloride converts the enzyme to Com-
pound III [55]. Superoxide can either inhibit or enhance production
of hypochlorous acid [55]. Thus, when using xanthine oxidase it is pru-
dent to check how superoxide influences the activity ofmyeloperoxidase
bymeasuring hypochlorous acid production in the presence and absence
of superoxide dismutase.
4. Standardizing reagent hypochlorous ccid
The concentration of analytical grade hypochlorous acid is best de-
termined by diluting it into 100 mM sodium hydroxide and then mea-
suring the absorbance of hypochlorite at 292 nm (ε292 350 M−1 cm−1)
[22]. The concentration of hypochlorous acid can be easily confirmed by
adding it, with vigorous mixing on a vortex, to a solution of 5 mM tau-
rine in phosphate buffer pH 7.4 to produce taurine chloramine. The
chloramine is then reacted with 5-thio-2-nitrobenzoic acid (TNB) to
bleach its yellow colour (ε412 14,100 M−1 cm−1) [56,57]. In this reac-
tion one mole of taurine chloramine oxidizes two moles of TNB to
give colourless 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB). It is not ad-
visable to react hypochlorous acid directly with TNB because it also ox-
idizes any DTNB that may be present in the original solution, giving an
under-estimate of its true concentration. When using solutions of
hypochlorous acid and chloramines it is imperative tomix them rapidly
and effectively with solutions of target molecules. Otherwise, reactions
will occur in localized areas giving stoichiometries and product distri-
butions that are not representative of a homogenous solution.
5. Measuring hypochlorous acid production by myeloperoxidase
Hypochlorous acid cannot bemonitoreddirectlywhen it is produced
by myeloperoxidase because it does not accumulate due to its rapid re-
actions with other constituents in solution including myeloperoxidase
[58,59] and hydrogen peroxide [60]. Reaction with myeloperoxidase
leads to enzyme inactivation [59]. Consequently, hypochlorous acid
has to be scavengedby a reagent that gives a change in absorbance,fluo-
rescence or chemiluminescence. Alternatively, it can be trappedwith an
amine such as taurine to give a stable chloramine.Whichever reagent is
chosen to scavenge hypochlorous acid, it is imperative that the reaction
is fast enough to prevent hypochlorous acid from reacting with other
components of the system and that the reagent does not react with com-
pound I to promote formation of compound II. Monochlorodimedon
satisfies the first criterion as a detector [28] but promotes accumula-
tion of compound II such that the chlorination activity is grossly
under-estimated [45]. Detectors that show decreased production
of hypochlorous acid when their concentration is increased should
be avoided because they are likely to promote accumulation ofcompound II [28]. The following are the preferred assays for measuring
hypochlorous acid production by purified myeloperoxidase. They are
readily adapted to also measure production of hypobromous acid
and hypoiodous acid by eosinophil peroxidase, lactoperoxidase, and
peroxidasin 1.
5.1. The taurine chloramine assay
In this assay hypochlorous acid is scavenged by taurine (5 mM)
to produce taurine chloramine, which retains the oxidizing capaci-
ty of hypochlorous acid but is considerably less reactive (Fig. 4, re-
action 1) [56]. Reactions are best started by adding hydrogen
peroxide (ε240 43.6 M−1 cm−1) [61] with mixing to the buffer con-
taining taurine, myeloperoxidase and chloride. Taurine chloramine
is stable at 37 °C for up to an hour. Solutions of taurine chloramine
can also be placed on ice until measured where they are stable for
hours. When other reagents are added to the buffer (e.g. potential
inhibitors of myeloperoxidase), it should first be ascertained whether
at the concentrations used they compete with taurine for reaction
with hypochlorous acid. It should also be checked that they do not
react with taurine chloramine. The main advantages of using taurine
to trap hypochlorous acid is that it does not interfere with the activity
of myeloperoxidase and the assay can be easily adapted to an ELISA
plate format. The disadvantage of this assay is that hypochlorous acid
production cannot bemonitored continuously but rather the accumula-
tion of taurine chloramine must be sampled at set intervals.
Taurine chloramine is easily assayed by measuring the extent to
which it oxidizes 3,3′,5,5′-tetramethylbenzidine (TMB) in a reaction
that is catalysed by iodide (Fig. 4, reactions 2&3) [62]. In this assay, tau-
rine chloramine formed by myeloperoxidase is added to a 2 mM solu-
tion of TMB in the presence of iodide at pH 5.4. TMB is oxidized to a
blue complex (ε650 ~ 30,000 M−1 cm−1) within five minutes [63].
Oxidation of TMB is much slower in the absence of iodide. Accurate
determination of the concentration of taurine chloramine formed
by myeloperoxidase is achieved by comparing results with a stan-
dard curve for reagent hypochlorous acid under the same conditions.
The need for iodide as a catalyst gives this assay additional specificity
for chloramines and distinguishes chloramines from bromamines
[64]. The latter oxidize TMB independently of iodide. Additional sensi-
tivity can be obtained by using dihydrorhodamine, which is oxidized
by taurine chloramine in the presence of iodide to give highly fluores-
cent rhodamine [62]. The advantages of these assays are that a chromo-
phore is produced rather than bleached, and that they are sensitive,
specific and adaptable to a range of formats for measuring single or
multiple samples.
Originally, taurine chloramine was measured by reacting it with
5-thio-2-nitrobenzoate (TNB) [57,65]. The advantages of using TNB
are that it gives a sensitive and accurate readout of the concentration
of taurine chloramine. Its chief disadvantage is that to obtain an ac-
curate measurement, a prior knowledge of the taurine chloramine
concentration is required so the initial concentration of TNB can be
adjusted to give the largest possible loss in absorbance. This aspect
complicates large scale analysis of hypochlorous acid production.
5.2. The NAD(P)H assay
Hypohalous acids react rapidly with NADH or NADPH to form
halohydrins that absorb maximally at 274 nm (Fig. 5) [66]. NADH is a
poor substrate formyeloperoxidase and does not interferewith enzyme
activity. Hence NADH is an ideal detector for continuously monitoring
the production of hypochlorous acid and hypobromous acid [67,68].
The absorbance of NADH (ε340 6200 M−1 cm−1) at 340 nm can also
be monitored to determine the oxidation of NADH and thereby assess
the stoichiometry of the reaction. The main disadvantage of this assay
is that, depending on what other components are present, NADH may
not always capture all of the hypochlorous acid that is generated. The
0 5 10 20 30 50 75 100   (µM HOCl)
Fig. 4. The taurine chloramine assay. Hypochlorous acid is captured in reaction 1 where it forms taurine chloramine. It is subsequently assayed by adding it to iodide in the presence of
3,3′,5,5′-tetramethylbenzidine. The iodide is oxidized to hypoiodous acid (reaction 2), which in turn reactswith TMB to form the blue diimine (reaction 3). The ELISAwells showoxidation
of TMB at increasing concentrations of hypochlorous acid (HOCl).
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competitive inhibitor of myeloperoxidase with respect to its reaction
with hydrogen peroxide [69].
5.3. The ascorbate assay
Ascorbate reacts rapidly with hypochlorous acid [41,70] and its con-
sumption can be monitored at 266 nm (ε266 15,000 M−1 cm−1) [71].
Thus, the oxidation of ascorbate can be used to continuously monitor
hypochlorous acid production by myeloperoxidase (Fig. 6) [71]. There
are several important caveats that must be appreciated when using the
ascorbate assay. Firstly, ascorbate is a substrate for myeloperoxidase,
reacting readily with both Compound I and Compound II [72]. However,
when used at 100 μMwith 140 mM chloride, it competes poorly for ox-
idation by Compound I. Under these conditions essentially all the oxida-
tion of ascorbate is via hypochlorous acid and little can be attributed to
direct oxidation by myeloperoxidase [69]. In contrast, any Compound IIFig. 5. Chlorination of NADH by myeloperoxidase. NADH (100 μM) was chlorinated by
adding 50 μM hydrogen peroxide to 20 mM phosphate buffer pH 7.4 containing
140 mM sodium chloride and 20 nM myeloperoxidase. The difference spectra against
NADH show the progress loss in absorbance at 340 nm due to oxidation of NADH and
the increase in 275 nm due to formation of chlorohydrin. Arrows indicate direction of
spectral changes over 5 min.that is formed in the ascorbate assay will be rapidly reduced back to
the ferric enzyme. Hence, inhibitors that act by promoting the accu-
mulation of Compound II will not be active in this assay. For exam-
ple, at 420 nM, dapsone inhibits consumption of hydrogen peroxide
by myeloperoxidase in the presence of chloride by 50% because it re-
duces Compound I to Compound II [51]. Yet in the ascorbate assay it
failed to inhibit myeloperoxidase (Fig. 6). This facet of the ascorbate
assay makes it ideal when trying to identify inhibitors that act in other
ways besides promoting accumulation of Compound II. This is illustrat-
ed in Fig. 6 where the suicide substrate 2-thioxanthine [73] was a good
inhibitor of myeloperoxidase in the presence of ascorbate. The assay
was also recently employed to show that ceruloplasmin is a potent
mixed type inhibitor of myeloperoxidase with respect to halides [69].
The maximum concentration of ascorbate that can be used in this
assay is about 140 μM otherwise its absorbance exceeds the limits ofFig. 6. Oxidation of ascorbate by myeloperoxidase. Ascorbate (100 μM) was oxidized by
adding 25 μM hydrogen peroxide (arrow) to 10 mM phosphate buffer pH 7.4 containing
140 mMsodiumchloride, 10 nMmyeloperoxidase (MPO) and 100 μMdiethyldiaminepenta
acetic acid. The loss in absorbance at 266 nmwasmonitoredwith the full reaction system, in
the absence of myeloperoxidase, in the presence of either 1 μM dapsone or 2 μM of
the 2-thioxanthine TX1.
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components in the system that react rapidly with hypochlorous acid.
5.4. Hydrogen peroxide consumption
The use of a hydrogen peroxide electrode to monitor hydrogen per-
oxide (ε240 43.6 M−1 cm−1) [61] consumption bymyeloperoxidase has
been described in detail previously [56]. In the presence of 140 mM
chloride and methionine (1 mM to scavenge hypochlorous acid), it
can be assumed to measure chlorination activity. Modern electrodes
are easier to use than the original Clarke-type electrode and provide a
sensitive measure of enzyme activity. They are useful for obtaining
kinetic constants for the steady state production of hypochlorous acid
and establishing how inhibitors affect enzyme activity [47,74]. Howev-
er, components in the system can interfere with the electrode signal
making it difficult to accurately recordhydrogen peroxide consumption.
Furthermore, the hydrogen peroxide electrode is useful for small scale
experiments only.
Hydrogen peroxide consumption can also be measured with good
sensitivity in a non-continuous assay using ferrous-iron oxidation of
xylenol (FOX assay) [75]. This is a colorimetric assay where ferrous am-
monium sulfate is oxidized by hydrogen peroxide leading to the forma-
tion of a blue-purple complex with xylene orange. The inclusion of
sorbitol amplifies ferrous oxidation via formation of hydroperoxyl radi-
cals, raising the sensitivity of the assay. When investigating reactions of
myeloperoxidase in the presence of 140 mMchloride and 1 mMmethi-
onine, detection of hydrogen peroxide consumption by the FOX assay
can be interpreted as a measure of hypochlorous acid production. In
our laboratorywe have found this to be a valuable assay that gives com-
parable inhibition data to that for othermeasures of the chlorination ac-
tivity of MPO. This assay is amenable to testing a variety of reaction
conditions and can be easily adapted to high throughput screening
using a plate reader.
6. Measuring hypochlorous acid production by neutrophils
6.1. Detection of extracellular hypochlorous acid
In our experience the taurine chloramine assay is the method of
choice for quantitative determination of extracellular production of
hypochlorous acid by stimulated neutrophils [50,62,64,76,77]. Neutro-
phils are incubated in Hanks buffered saline solution containing 5 mM
taurine at pH 7.4 and 37 °C and then stimulated with either phorbol
myristate ester (PMA), formyl-Met-Leu-Phe or opsonized zymosan.
After set time intervals, reactions are stopped by adding catalase
(10 μg/ml) to remove residual hydrogen peroxide, cells pelleted by
centrifugation, and the accumulated taurine chloramine detected
using iodide-catalysed oxidation of TMB as described above. Normally,
2 × 106 neutrophils per ml will produce about 50 μM hypochlorous
acid in 30 min when stimulated with PMA. The advantages of this
assay are that it is simple, sensitive, and specific. The limitations
are that it is not possible to continuously monitor the formation of
hypochlorous acid and taurine chloramine may react with constituents
in the reaction systems. This latter possibility should be assessed for
each component in the system before commencing experiments with
cells.
Oxidation of methionine tomethionine sulfoxide can also be used to
quantitatively determine hypochlorous acid production by neutrophils
[78,79]. The rapid reaction of methionine with hypochlorous acid en-
sures that at sufficiently high concentrations of methionine all the
hypochlorous acid can be trapped [28]. Also, methionine sulfoxide is
stable and in the presence of excess methionine is relatively unreactive
to further oxidation. The presence of contaminatingmethionine sulfox-
ide in purified methionine or artefactual oxidation of methionine can
limit the sensitivity of this assay. Amajor drawback is that the detection
of methionine sulfoxide requires a derivatisation procedure coupledwith HPLC or direct analysis using liquid chromatography with mass
spectrometry [78,79].
6.2. Detection of hypochlorous acid inside neutrophil phagosomes
It is necessary to measure hypochlorous acid inside neutrophil
phagosomes to understand what factors are crucial for its efficient pro-
duction, whether its production is compromised in certain immune de-
fects, such as cystic fibrosis, andwhether pathogenic bacteriamay block
its formation. It is not sufficient to justmeasure its extracellular produc-
tion because conditions within phagosomes are vastly different to the
surrounding milieu. Concentrations and fluxes of participants required
to form and consume hypochlorous acid are markedly elevated in the
tiny space available within the phagosomes [80]. For example, it has
been estimated that the concentration of myeloperoxidase is relatively
enormous at approx. 1 mM, the flux of superoxide incredibly fast at
2 mM/s, and the concentration of amino acid residues is about 1.5 M
[80]. The concentration of chloride is likely to be similar inside and out-
side the phagosome but this has yet to be unequivocally established
[81]. Kinetic modelling of oxidant production leads to predictions that
under optimal conditions most of the superoxide generated by the
NADPH oxidase inside phagosomes is converted to hypochlorous acid
[80]. Furthermore, if it were to accumulate, the concentration of this ox-
idant should be in the hundreds of millimolar. Thus, it would be natural
to expect that measurement of hypochlorous acid inside phagosomes
should be a trivial task. Nothing could be further from the truth. This
is because most of the hypochlorous acid is expected to react with neu-
trophil proteins inside the phagosome. Consequently its measurement
is fraught with all the difficulties of detecting a transient oxidant that re-
acts bymultiple routes and leaves the same chemical footprints as several
other reactive oxygen species. The challenge of measuring hypochlorous
acid inside neutrophil phagosomes requires a probe that captures enough
oxidant to reflect its kinetics and extent of formation, and preferably re-
tains chlorine as a molecular foot print.
Several approaches have been used to detect hypochlorous acid in
phagosomes. In most studies bacteria ingested by neutrophils have
been used as the probes for hypochlorous acid. Initially, it was shown
that tyrosine residues in bacterial proteins are chlorinated to form the
stable and specific product 3-chlorotyrosine that was detected using sta-
ble isotope dilution mass spectrometry [82,83]. Bacteria were grown
with a heavy isotope of tyrosine to unequivocally demonstrate that the
chlorinated product originated from the bacteria and not neutrophil pro-
tein [82]. This method has been used to show that there is a defect in
phagosomal production of hypochlorous acid in neutrophils from pa-
tientswith cysticfibrosis [84]. Its strengths are its high degree of sensitiv-
ity and specificity for reactive chlorine species. However, its weakness is
that 3-chlorotyrosine is a minor product when hypochlorous acid reacts
with proteins [85,86]. Therefore, detection of 3-chlorotyrosine will rep-
resent only a small percentage of the total hypochlorous acid produced.
As a consequence it may not be a good barometer of subtle changes in
oxidant generation.
To overcome the problem of a low yield biomarker, Rosen et al. used
liquid chromatographywithmass spectrometry tomeasuremethionine
sulfoxide in bacterial proteins after the bacteria had been ingested and
killed by neutrophils [83]. Methionine sulfoxide was detected by an in-
crease of 16 mass units in tryptic peptides of bacterial proteins that
contained methionine. Approximately 50% of bacterial methionine res-
idueswere oxidized in a process thatwas reliant on theNADPH oxidase,
myeloperoxidase and chloride. These results suggest that bacterial me-
thionine sulfoxide is a good biomarker of hypochlorous acid production
inside phagosomes. However, it should be remembered that methio-
nine sulfoxide is not a specific for hypochlorous acid and other oxidants
may contribute to the signal [87].
Expression of green fluorescent protein (GFP) in the cytosol of bac-
teria has been used to visualise hypochlorous acid production during
killing of ingested micro-organisms [88,89]. GFP is highly sensitive to
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conundrumwith this approach is that bacterial viability was lost much
more rapidly than the GFPwas bleached. Chlorination of the fluorescent
tyrosyl residue in GFP is expected to be slow, so it may not occur until
the more reactive reductants inside the bacteria are consumed. Expres-
sion of GFP on the outside of bacteria may overcome this problem.
An alternative approach to the abovemethods is to couple a probe to
a phagocytosable particle and subsequently measure its degree of oxi-
dation or chlorination. In an example of this method fluorescein was
conjugated to polyacrylamide microspheres via a reducible cystamine
disulphide bond [90,91]. When phagocytosed it underwent almost com-
plete conversion to chlorinated derivatives that were detected using liq-
uid chromatography with mass spectrometry. Chlorination coincided
with phagocytosis and the respiratory burst of the neutrophils. This
method has the advantage of detecting a relatively abundant biomarker
that is specific for hypochlorous acid. However, unlike the approaches
described above using bacteria, it cannot be directly related to defects
in killing of particular micro-organisms. A related method, in which
dichlorodihydrofluorescein was conjugated to yeast, demonstrated the
kinetics for hypochlorous acid production inside the phagosomes of a
myeloid cell line [92]. Hypochlorous acid reacted with the probe to
give a unique red-shifted fluorescence that was used to image oxidant
production during phagocytosis.
6.3. Detection of hypochlorous acid using reaction-based fluorescent probes
In recent years numerous small molecule reaction-based indicators
for hypochlorous acid have been ingeniously constructed to exploit the
fluorescent properties of rhodamine, BODIPY, and fluorescein [93–103].
These probes have a reactive group that is oxidized by hypochlorous
acid to unmask the fluorescent moiety (Fig. 7). They are stable to
photo-bleaching and, given their high sensitivity, are ideal for monitor-
ing hypochlorous acid production in biological systems. They are better
probes than dichlorofluorescein and rhodamine because they have
greater specificity and are less prone to artefactual oxidation [104]. The
probes were used to visualize the production of hypochlorous acid with-
in neutrophils and macrophages [97,99]. Co-localisation of fluorescenceA
Fig. 7.Unmasking a reaction-based fluorescent probe for hypochlorous acid. Reaction of the probe
were incubated in Hanks buffer pH 7.4 at 37 °C with 10 μMR19-S and stimulated with opsonized
inhibitor 10 μM diphenyliodonium. Hypochlorous acid is visualized (B) by the red fluorescenc
Olympus IX81 live cell imaging microscope with an XM10 camera (20 times objective) using Cwith the ingestible provides additional evidence that hypochlorous
acid is produced inside phagosomes and therefore a component of the
neutrophil's antimicrobial arsenal (Fig. 7).
Recently cadmium-selenide quantum dots were developed as a
probe for hypochlorous acid to overcome some of these limitations be-
cause they exhibit superior photophysical properties [105]. The quan-
tum dots had good sensitivity and specificity and were used to show
production of hypochlorous acid in HL60 cells. However, their utility
still needs to be examined in neutrophils.
The results to date with fluorescent probes demonstrate their excit-
ing potential to monitor in real time the kinetics of hypochlorous acid
productionwithin neutrophil phagosomes andhow thismaybemodulat-
ed. They also have potential to illustrate the temporal and spatial produc-
tion of hypochlorous acid production by neutrophils andmacrophages as
they interact with immune complexes and host tissue during inflamma-
tory pathologies. However, before being captivated by the visual splen-
dour of these probes and their potential to reveal novel aspects of
oxidative biology, their inherent shortcomings need to be understood.
Thiswill ensure that results obtainedwith themare interpretedwith cau-
tion and new generations of probes are designed to overcome their cur-
rent limitations. The challenges of using fluorescent probes to detect
and quantify specific reactive oxygen species in livings cells has been crit-
ically evaluated elsewhere in this series [104].
Although the probes have been reported to be specific for
hypochlorous acid, the range of other oxidants tested against the
probes has in general been limited to superoxide, hydrogen peroxide,
hydroperoxides, singlet oxygen, hydroxyl radical, peroxyl radical, and
peroxynitrite. Related halogen-derived oxidants such as hypobromous
acid, chloramines, bromamines, and hypothiocyanite have not been
assessed. Testing these species will be necessary to establish specificity
because oxidants spawned from bromide are produced by both neutro-
phils and eosinophils [76,106]. Consequently, in vivo fluorescence could
originate from either cell type. Also, chloramines retain some of the ox-
idizing potential of hypochlorous acid and slowly breakdown to release
ammonia chloramine and ammonia dichloramine [32]. Therefore, the ki-
netics for the oxidationof theprobesmaybedeterminedby the chemistry
of the chloramines rather than the formation of hypochlorous acid. InB
R19-Swith hypochlorous acid to produce its fluorescent product. Neutrophils (1 × 106/ml)
zymosan (2 × 107 particles/ml) in the (A) presence and (B) absence of the NADPH oxidase
e associated with the phagocytozed zymonsan particles. The images were taken using an
Y3 and differential interference contrast.
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thiols and seleno compounds but poorlywithmost other biological nucle-
ophiles [107,108]. Hence, these probes, particularly the selenoether types
[96], may be oxidized to a greater extent by hypothiocyanite than
hypochlorous acid simply because the latter oxidant has multiple other
targets.
Some alternative unmasked probes may also be prone to direct oxi-
dation bymyeloperoxidasewithout the need for hypochlorous acid pro-
duction. The sulfonapthoaminophenyl fluorescein probe is a case in
point [51]. This probe contains an aniline group that could be readily
oxidized by myeloperoxidase. It also has the potential to be an inhibitor
of hypochlorous acid production by promoting the accumulation of
compound II. These aspects of reaction-based indicators should be thor-
oughly assessed before assuming myeloperoxidase oxidizes them effi-
ciently via the production of hypochlorous acid.
Currently, there is limited information on the rates of reaction of
the probes with hypochlorous acid. Rate constants for these reac-
tions are needed to assess whether the probes will be major targets
for hypochlorous acid within phagosomes or at sites of inflamma-
tion. Therefore, at this time they cannot be used to provide quantita-
tive or even semi-quantitative data on the yields of hypochlorous
acid produced by immune cells under various settings. Also, if the
fluorescent yields are too low, they may not fully represent the ki-
netics of hypochlorous acid production. The probes with sulfur or
selenoether [96] oxidisable moieties show promise as quantitative
probes but those with alkene groups [109] are likely to be too
unreactive to compete with biological targets.
Another issue with the use of the probes is that there is currently no
way of determining the yield of the fluorescent species compared to the
parent. Consequently, a high signalmay result from either extensive ox-
idation of the probe or accumulation of large amounts of its oxidized
form at a particular location in cells or tissue. The new generation of
ratiometric fluorescent probes should assist in providing quantitative
measurements via self-calibration of two emission bands [109,110].
When used critically, the current probes are useful for illustrating forma-
tion of hypochlorous acid inside phagosomes. Their future development
will undoubtedly advance our understanding of how hypochlorous acid
contributes to host defence and inflammation.
7. Finding evidence of hypochlorous acid production
during inflammation
Neutrophils play a pivotal role in numerous pathologies. They com-
bat infections, resolve inflammation by assisting inwound debridement
[111], but exacerbate inflammation in diseases such as rheumatoid ar-
thritis [112], cysticfibrosis [113], chronic obstructive pulmonary disease
[114], gout [115], atherosclerosis [116], and sepsis [117]. There is also an
increasing focus on how neutrophils are exploited by cancer cells to
promote their own growth, invasion and metastasis [118]. Linking
hypochlorous acid to these pathologies requires the use of specific and
sensitive biomarkers that will unequivocally demonstrate its genera-
tion at sites of inflammation and that thesemolecular footprints are as-
sociated with disease severity. Their attenuation by drugs that target
myeloperoxidase and alleviate disease will be the ultimate proof that
hypochlorous acid has a causal role in a particular pathology.
An ideal biomarker for hypochlorous acid is a specific and stable
product of its fast reaction with a biological molecule. This product
should be amenable to sensitive and quantitative analysis. The most
specific products are those that contain a chlorine atom. However, chlori-
nation reactions of hypochlorous acid aremuch slower than its oxidation
reactions [11]. Protein chloramines are likely to be abundant products but
they react readily with reducing compounds, such as ascorbate, and
thiols. They are also unstable and breakdown to generate protein car-
bonyls that are not specific to hypochlorous acid [86,119]. Chlorination
of the vinyl ethermoiety of plasmalogens produces a range of chlorinated
metabolites [120,121]. Their chlorination is relatively favourable becausethe ether group alpha to the double bond facilitates the reaction com-
pared to that for a simple double bond in lipids [122]. The latter also
gives rise to chlorohydrins but via a slow reaction [123]. Direct
chlorination of tyrosyl residues to form 3-chlorotyrosine is also
slow [28]. In proteins, chlorination of tyrosyl residues most likely
occurs via a juxtaposed chloramine [124,125]. The biological stabil-
ity of 3-chlorotyrosine has been questioned because it can be me-
tabolized to 4-hydroxyphenylacetic acid [126] or may be further
chlorinated or nitrated [127,128]. As discussed above, NAD(P)H is
readily chlorinated by hypochlorous acid to form chlorohydrins.
However, given the relatively low concentration of NAD(P)H in
cells, it is unlikely that they would be chlorinated at sites of inflam-
mation. DNA bases are also chlorinated to give 8-chloroguanosine,
5-chlorocytosine, and 5-chlorouracil [129–134]. These reactions are rel-
atively slow [135] and although 5-chlorouracil has been detected in in-
flammatory tissues [132,133], it was suggested that little hypochlorous
acid can diffuse across the cytoplasm of cells and react with DNA to pro-
duce a useful biomarker [136]. However, chlorinated and brominated
products of deoxyguanosine have been detected in urine of healthy in-
dividuals [137]. These levelswere increased eight fold in diabetics. Thus,
halogenated deoxyguanosines have potential as biomarkers of oxida-
tive stress during inflammation.
Although oxidation reactions of hypochlorous acid are favourable, in
general they do not furnish specific products [25]. Fortunately, there are
some interesting exceptions. These involve the reactions of hypochlorous
acid with thiols and methionine. In both cases the initial product is a
sulfenyl chloride [138,139]. This normally hydrolyses to produce a
sulfenic acid or sulfoxide, respectively. Sulfenic acids can react fur-
ther to produce a disulfide [140]. However, when the sulfenyl chloride
is in close proximity to a nucleophilic amine group, sulfenamides are
also produced with good yields. These are further oxidized to sulfon-
amides. Although these products are not restricted to reactions of
hypochlorous acid, few other biological oxidants produce them and,
when measured in combination with myeloperoxidase, they provide a
good degree of specificity. Hypochlorous acid was first shown to pro-
duce a sulfonamide when it reacts with glutathione [138]. Related
sulfinamides were then found in the neutrophil protein calprotectin
after it was oxidized by a modest dose of hypochlorous acid [141,142].
Oxidized calprotectin is present in sputum fromasthmatics, which indi-
cates this chemistry is relevant to neutrophilic inflammation [143].
Hypochlorous acid is likely to form these bonds within and between
other proteins based on the susceptibility of cysteine containing pep-
tides to form intra and intermolecular sulfenamides, sulfinamides and
sulfonamides [144]. Methionine and peptides with N-terminal methio-
nine residues afford the analogous compound dehydromethionine in
good yields [145]. This is a cyclic product in which the sulfur atom of
the methionine side chain becomes bonded to the N-terminal amine.
Ubiquitin forms this product in high abundance as should other pro-
teins with an N-terminal methionine [146]. Recently, it was found
that upon reaction with hypochlorous acid the γ-glutamyl residues of
glutathione disulfide are converted to 5-hydroxybutyrolactams [147].
These products were suggested to be specific and potential biomarkers
for the activity of myeloperoxidase.
Given the various pros and cons of the potential biomarkers for
hypochlorous acid, the following established methods are recommend-
ed for tracking its production in vivo and attempting to show its rele-
vance to pathology.
7.1. Detection of 3-chlorotyrosine
Currently, measurement of 3-chlorotyrosine (Fig. 8) in proteins is the
gold standard for detecting production of hypochlorous acid in vivo. Its
strengths as a biomarker are that it is highly specific, there are very
sensitive and robust methods using mass spectrometry for its detec-
tion [148,149], and its levels correlate strongly with the presence of
myeloperoxidase. Normally proteins collected from sites of inflammation
Fig. 8. Biomarkers for hypochlorous acid formed in its reactions with biomolecules. Chlo-
rination of tyrosine residues produces 3-chlorotyrosine, while hypochlorous acid converts
plasmalogens to α-chlorofatty aldehydes, alcohols, and acids, as well as 2-chloroadipic
acid. Oxidation of glutathione produces glutathione sulfonamide as a minor but specific
product.
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and tyrosine [148,149]. Methanesulfonic acid is the preferred acid for hy-
drolysis because artefactual halogenation of tyrosine is minimized com-
pared to that observed with hydrochloric or hydrobromic acids [150].
Stable isotopes of 3-chlorotyrosine and tyrosine are included in the hy-
drolysis to check for artefactual chlorination of tyrosine. They also provide
accurate quantitative analysis by accounting for loses during sample han-
dling and diminution of signals due to ion suppression that may occur in
themass spectrometer. In the originalmethod using gas chromatography,
the amino acids were derivatized to make them volatile and then
analysed based on their specific ion fragments plus the characteristic
3:1 ratio of isotopes for molecules containing a chlorine atom. The con-
centrations of 3-chlorotyrosine and tyrosine are calculated by comparing
their signals to those for the known amounts of their stable isotopes that
were added before hydrolysis. The level of 3-chlorotyrsine is then report-
ed in μmoles per mol of tyrosine. In recent times liquid chromatography
with mass spectrometry has superseded gas chromatography as the
method of choice for 3-chlorotyrosine [151]. It has the advantage that it
is unnecessary to derivatize the amino acids, which decreases the chance
of chlorination during sample preparation. There are comparable levels of
sensitivity between the two techniques. Other aspects of this stable iso-
tope dilution assay are essentially the same as in the original method.
Detection of 3-chlorotyrosine was used to show that hypochlorous
acid is produced in the plaques of individuals with atherosclerosis
[149,152], joints of patients with rheumatoid arthritis [153], and in the
airways preterm infants [154] and children with cystic fibrosis [155]. In
each case the levels of 3-chlorotyrosine correlatedwithmyeloperoxidase.
Importantly, its levels were abrogated in myeloperoxidase-knockout ani-
mals when studying the role of the enzyme inmouse models of infection
[156] and inflammation [157].The major limitation with measuring 3-chlorotyrsoine/tyrosine in
biological samples is that the signal is diluted out by all the tyrosine
that is liberated from oxidized as well as unaffected proteins. To avoid
this problem it is best to sample the physical sitewheremyeloperoxidase
is active and target proteins in these sites that are subjected to high doses
of hypochlorous acid. Evengreater sensitivity is achievedby analysing the
tyrosine-containing peptides within these proteins that are most recep-
tive to chlorination. This approach was used to show that high density
lipoprotein (HDL) in atherosclerotic lesions contains high levels of
3-chlorotyrosine even when the signal in plasma was no higher than
in healthy controls [158]. It was then demonstrated that apoliprotein
A-1, the major protein in HDL, was selectively targeted for chlorination
[151] and that specific tyrosine residues in the protein were the major
sites for chlorination [159,160]. Subsequently, it was found the tryptic
peptide LAEYAK from apo-A1 in HDL isolated from atherosclerotic le-
sions is highly chlorinated compared to plasma from the same patients
[161]. This latter study highlighted the power of tandem mass spec-
trometry to detect 3-chlorotyrosine in selected proteins by monitoring
specified tryptic peptides and their chlorinated forms. The degree of
chlorination of these peptides can be used as a barometer to gauge
the extent to which hypochlorous acid contributes to inflammatory tis-
sue damage.
7.2. Detection of chlorinated products of plasmalogens
Plasmalogens are the major phospholipids of the plasma membranes
of endothelial and vascular smooth muscle cells and cardiac myocytes.
When hypochlorous acid reacts with their vinyl ether group it releases
α-chlorofatty aldehydes (Fig. 8), such as 2-chlorohexadecanal [121].
These products are then oxidatively and reductively metabolized to 2-
chlorofatty acids and 2-chlorofatty alcohols [162]. Further metabolism
of 2-chlorohexadonic acid affords 2-chloradipic acid (Fig. 8). These com-
pounds are excellent biomarkers for hypochlorous acid because they re-
tain the chlorine atom, and are produced by neutrophils [120,163] and
monocytes [120] in vivo by a myeloperoxidase-dependent process. They
are also amenable to quantitative and sensitive detection using mass
spectrometry. They have been detected in atheroma [164] and in LDL
from atherosclerotic lesions [165], while 2-chloradipic acid is excreted
in the urine of humans and rats [166]. 2-Chlorohexadecanal is detected
by gas chromatography with mass spectrometry after derivatisation
while its metabolites are measured using liquid chromatography with
tandem mass spectrometry. An excellent recent review describes these
methods in detail [167]. Quantitative analyses of these novel chlorinated
lipids should complement the information gained from investigating
chlorination of proteins and enhance the understanding of how oxidation
of lipids contributes to leukocyte-mediated injury and disease. Detection
of 2-chloroadipic acid has the added advantage that it is the only biomark-
er of hypochlorous that can be measured with assurance in urine.
7.3. Detection of glutathione sulfonamide
Glutathione sulfonamide (Fig. 8) is a stable product formed in good
yields via a fast reaction of glutathione (Glu-Cys-Gly) with hypochlorous
acid [138,139]. The sulfonamide linkage encompasses the sulfur atom of
the cysteine residue and the amine moiety of the N-terminal glutamate
residue. Linked together they form a nine membered cyclic struc-
ture [168]. Its formation is sufficiently selective for hypochlorous acid
to make it a good biomarker. Hypobromous acid and peroxynitrite can
form glutathione sulfonamide but in much lower yields [139]. Glutathi-
one sulfonamide is produced when neutrophils and endothelial cells
are treated with hypochlorous acid but in much lower yields than glu-
tathione disulfide (GSSG) [169]. Clinical studies looking for the forma-
tion of glutathione sulfonamide have focused on respiratory diseases
because the concentration of glutathione in epithelial lining fluid is rel-
atively high at about 400 μM [170]. Hence, glutathione in the airways is
a likely target for any hypochlorous acid produced by stimulated
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the lung lavage fluid from pre-term babies with respiratory infections
[171]. In these samples, its concentration correlated with levels of
both myeloperoxidase and 3-chlorotyrosine in proteins. These results
supported its use as a biomarker of hypochlorous acid. Glutathione
sulfonamide showed better sensitivity and selectivity for detecting
bacterial growth than the either myeloperoxidase or 3-chlorotyrosine.
Consequently, it has potential for detecting lung infections. In support
of this claim, glutathione sulfonamide is also produced in the airways
of childrenwith cystic fibrosis [171]. Its levels are elevated in those chil-
dren with respiratory infections compared to those without infections
(unpublished result).
Glutathione sulfonamide is detected using liquid chromatogra-
phy with stable isotope dilution tandem mass spectrometry [169].
The method is sensitive and quantitative with a limit of quantitation
of 0.1 pmol. Immediately upon collection, samples are treated with
N-ethylmaleimide to block the unreacted thiol group on glutathione
to form an adduct (GS-NEM). Before analysis stable heavy isotopes
of glutathione sulfonamide, GSSG and GS-NEM are added to the sam-
ple and proteins are precipitated. The analytes and their respective
isotopes are then separated by reversed phase liquid chromatography
and detected by selected reaction monitoring. The heavy isotopes are
essential for accurate quantification as they account for losses during
sample handling and ion suppression during analysis in the mass spec-
trometer. This method has potential to detect glutathione sulfonamide
in plasma and urine. It should havewide applicability for demonstrating
production of hypochlorous acid in inflammatory diseases. Themethod
will also be useful for understanding the degree to which hypochlorous
acid contributes to oxidation of glutathione in the airways.
8. Future prospects for biomarkers of hypochlorous acid
The continued pursuit of additional biomarkers for hypochlorous
acid is likely to be rewarding. This is because more abundant products
of the reactions of hypochlorous acid with biomolecules await discov-
ery. These will include the specific oxidation products of cysteine and
methionine residues on proteins. Thus, identification of sulfonamides
within and between proteins should be fruitful as should the detection
of dehydromethionine on the N-terminal of proteins. Indeed, we have
found that the N-terminal methionine of calprotectin S100 A8 is
converted to dehydromethionine and it is readily detected in broncho-
alveolar lavage fluid from children with cystic fibrosis (Magon et al.
unpublished). Development of specific antibodies to footprints of chlo-
rine would be a huge advantage to show by immunohistochemistry
where hypochlorous acid reacts in cells and tissue. Good results have
been obtained with the HOP1 antibody to hypochlorous acid-modified
proteins [172] but it also recognizes proteins oxidized by hypobromous
acid [86]. Finally, further development of specific and sensitive reaction-
based fluorescent probes should eventually illuminate the importance
of hypochlorous acid in innate immunity and inflammation.
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